Increased incidence of Parkinsonism among Chinese with β-glucosidase mutation in central Taiwan

Gelb, 1999, Diagnostic criteria for Parkinson disease, Arch Neurol, 56, 33, 10.1001/archneur.56.1.33 Hughes, 1992, Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases, J Neurol Neurosurg Psychiatr, 55, 181, 10.1136/jnnp.55.3.181 Deng, 2005, Genetic analysis of parkin co-regulated gene (PACRG) in patients with early-onset parkinsonism, Neurosci Lett, 382, 297, 10.1016/j.neulet.2005.03.034 Zimprich, 2004, Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology, Neuron, 44, 601, 10.1016/j.neuron.2004.11.005 Paisín-Ruiz, 2004, Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease, Neuron, 44, 595, 10.1016/j.neuron.2004.10.023 Polymeropoulos, 1997, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, 276, 2045, 10.1126/science.276.5321.2045 Kitada, 1998, Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism, Nature, 392, 605, 10.1038/33416 Bonifati, 2003, DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism, Neurol Sci, 24, 159, 10.1007/s10072-003-0108-0 Valente, 2004, Hereditary early-onset Parkinson's disease caused by mutations in PINK1, Science, 304, 1158, 10.1126/science.1096284 Funayama, 2002, A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1, Ann Neurol, 51, 296, 10.1002/ana.10113 Horowitz, 1989, The human glucocerebrosidase gene and pseudogene: structure and evolution, Genomics, 4, 87, 10.1016/0888-7543(89)90319-4 Winfield, 1997, Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease, Genome Res, 7, 1020, 10.1101/gr.7.10.1020 Filocamo, 2002, Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian Gaucher patients, Hum Mutat, 20, 234, 10.1002/humu.9058 Beutler, 2005, Hematologically important mutations: Gaucher disease, Blood Cells Mol Dis, 35, 355, 10.1016/j.bcmd.2005.07.005 Stone, 2000, Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease, Hum Mutat, 15, 181, 10.1002/(SICI)1098-1004(200002)15:2<181::AID-HUMU7>3.0.CO;2-S Singh, 2008, Polymorphism in environment responsive genes and association with Parkinson disease, Mol Cell Biochem, 312, 131, 10.1007/s11010-008-9728-2 Kuehn, 2006, Scientists probe role of genes, environment in Parkinson disease, JAMA, 295, 1883, 10.1001/jama.295.16.1883 Hughes, 2001, Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease, Neurology, 57, 1497, 10.1212/WNL.57.8.1497 Ida, 1995, Characteristics of gene mutations among 32 unrelated Japanese Gaucher disease patients: absence of the common Jewish 84GG and 1226G mutations, Hum Genet, 95, 717, 10.1007/BF00209497 Ida, 1999, Clinical and genetic studies of Japanese homozygotes for the Gaucher disease L444P mutation, Hum Genet, 105, 120, 10.1007/s004390051073 Cullen, 2011, Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing, Ann Neurol, 69, 940, 10.1002/ana.22400 Kim, 2012, Simultaneous detection of Gaucher's disease and renal involvement of non-Hodgkin's lymphoma: the first Asian case report and a review of literature, Ann Clin Lab Sci, 42, 293 Neudorfer, 1996, Occurrence of Parkinson's syndrome in type I Gaucher disease, QJM, 89, 691, 10.1093/qjmed/89.9.691 Tayebi, 2003, Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?, Mol Genet Metab, 79, 104, 10.1016/S1096-7192(03)00071-4 Wong, 2004, Neuropathology provides clues to the pathophysiology of Gaucher disease, Mol Genet Metab, 82, 192, 10.1016/j.ymgme.2004.04.011 Goker-Alpan, 2006, Glucocerebrosidase mutations are an important risk factor for Lewy body disorders, Neurology, 67, 908, 10.1212/01.wnl.0000230215.41296.18